ZA201304052B - Peg or peg block copolymers for treating colorectal cancer - Google Patents

Peg or peg block copolymers for treating colorectal cancer

Info

Publication number
ZA201304052B
ZA201304052B ZA2013/04052A ZA201304052A ZA201304052B ZA 201304052 B ZA201304052 B ZA 201304052B ZA 2013/04052 A ZA2013/04052 A ZA 2013/04052A ZA 201304052 A ZA201304052 A ZA 201304052A ZA 201304052 B ZA201304052 B ZA 201304052B
Authority
ZA
South Africa
Prior art keywords
peg
block copolymers
colorectal cancer
treating colorectal
peg block
Prior art date
Application number
ZA2013/04052A
Other languages
English (en)
Inventor
Peter Stein
Samuel H Smith
Jorg Plessl
Rachel Charlton
Ian Cox
Leighton Jones
Vries Corinne De
Original Assignee
Norgine Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norgine Bv filed Critical Norgine Bv
Publication of ZA201304052B publication Critical patent/ZA201304052B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/77—Polymers containing oxygen of oxiranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
ZA2013/04052A 2010-11-04 2013-06-03 Peg or peg block copolymers for treating colorectal cancer ZA201304052B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1018650.0A GB201018650D0 (en) 2010-11-04 2010-11-04 Methods and compositions
US41212810P 2010-11-10 2010-11-10
PCT/GB2011/001561 WO2012059725A1 (en) 2010-11-04 2011-11-04 Peg or peg block copolymers for treating colorectal cancer

Publications (1)

Publication Number Publication Date
ZA201304052B true ZA201304052B (en) 2014-02-26

Family

ID=43414365

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2013/04052A ZA201304052B (en) 2010-11-04 2013-06-03 Peg or peg block copolymers for treating colorectal cancer

Country Status (22)

Country Link
US (2) US20130216493A1 (https=)
EP (1) EP2635289B1 (https=)
JP (1) JP5917537B2 (https=)
KR (1) KR20130109171A (https=)
CN (1) CN103313719A (https=)
AR (1) AR083770A1 (https=)
AU (1) AU2011324996B2 (https=)
BE (1) BE1019494A3 (https=)
BR (1) BR112013011012A2 (https=)
CA (1) CA2816839A1 (https=)
EA (1) EA201300540A1 (https=)
ES (1) ES2401269B1 (https=)
GB (1) GB201018650D0 (https=)
MX (1) MX349690B (https=)
MY (1) MY163067A (https=)
NL (1) NL2007715C2 (https=)
NZ (1) NZ611145A (https=)
SG (1) SG189533A1 (https=)
TW (1) TWI606832B (https=)
UA (1) UA107998C2 (https=)
WO (1) WO2012059725A1 (https=)
ZA (1) ZA201304052B (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI535461B (zh) 2011-03-11 2016-06-01 諾金私人有限公司 結腸清潔溶液、用於製備該溶液之組成物、包含該組成物或溶液之套組、與製備該溶液之方法
MX382868B (es) 2012-09-11 2025-03-13 Norgine Bv Composiciones que comprenden polietilenglicol y ascorbato.
AR093153A1 (es) * 2012-10-26 2015-05-20 Northshore Univ Healthsystem Composiciones que comprenden polietilenglicol para la terapia del carcinoma de celulas escamosas de cabeza y cuello
CN103083733A (zh) * 2013-02-19 2013-05-08 华熙福瑞达生物医药有限公司 一种医用体腔器械导入水性润滑剂
EP3934661B1 (en) 2019-03-05 2025-04-02 Dow Global Technologies LLC Inducing caspase activity for treating colorectal cancer with polymers
WO2020180555A1 (en) * 2019-03-05 2020-09-10 Dow Global Technologies Llc Polyethyleneglycol derivatives for inducing caspase activity
WO2020180581A1 (en) 2019-03-05 2020-09-10 Dow Global Technologies Llc Inducing caspase activity

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2784897B1 (fr) * 1998-10-27 2002-11-29 Agronomique Inst Nat Rech Utilisation d'un laxatif osmotique non fermente dans le traitement et la prevention des cancers colorectaux
EP1877039A4 (en) * 2005-05-06 2010-08-18 Salix Pharmaceuticals Inc Polyethylene glycol GUT CLEANING COMPOSITION
US8457025B2 (en) * 2009-08-28 2013-06-04 Telefonaktiebolaget L M Ericsson (Publ) Method and network node for selecting a network prefix to be advertised in a communication network

Also Published As

Publication number Publication date
BE1019494A3 (fr) 2012-07-03
NL2007715A (en) 2012-05-07
MX349690B (es) 2017-08-09
AU2011324996A1 (en) 2013-05-02
GB201018650D0 (en) 2010-12-22
MY163067A (en) 2017-08-15
TW201304785A (zh) 2013-02-01
WO2012059725A1 (en) 2012-05-10
US20160228467A1 (en) 2016-08-11
MX2013004963A (es) 2013-08-27
EA201300540A1 (ru) 2013-09-30
NZ611145A (en) 2015-07-31
EP2635289B1 (en) 2020-03-11
KR20130109171A (ko) 2013-10-07
ES2401269B1 (es) 2014-02-19
AU2011324996B2 (en) 2015-10-08
WO2012059725A8 (en) 2013-05-30
TWI606832B (zh) 2017-12-01
UA107998C2 (uk) 2015-03-10
CA2816839A1 (en) 2012-05-10
ES2401269A1 (es) 2013-04-18
BR112013011012A2 (pt) 2016-08-23
CN103313719A (zh) 2013-09-18
NL2007715C2 (en) 2012-10-16
EP2635289A1 (en) 2013-09-11
JP2013544809A (ja) 2013-12-19
AR083770A1 (es) 2013-03-20
JP5917537B2 (ja) 2016-05-18
SG189533A1 (en) 2013-05-31
US20130216493A1 (en) 2013-08-22

Similar Documents

Publication Publication Date Title
PL2542585T3 (pl) Sposoby leczenia nowotworu jelita grubego
HRP20180882T1 (hr) Sredstva za i postupci liječenja dlbcl
PL2925888T3 (pl) Kompozycje i sposoby do stosowania w leczeniu nowotworów
PL3967315T3 (pl) Akkermansia muciniphila do leczenia nowotworu złośliwego
SG10201500124VA (en) Methods and Compositions for Treating Cancer
IL227429A0 (en) The components and methods of cancer treatment
PL2532366T3 (pl) Kompozycja farmaceutyczna do leczenia i/lub zapobiegania nowotworowi
PL2428229T5 (pl) Onkolityczne adenowirusy do leczenia raka
IL218987A0 (en) Methods and compositions for treating cancer
ZA201205004B (en) Methods for treating pancreatic cancer
BR112013011659A2 (pt) métodos de tratamento do câncer
ZA201304052B (en) Peg or peg block copolymers for treating colorectal cancer
IL216190A0 (en) Oncolytic adenoviruses for treating cancer
GB0804496D0 (en) Treating cancer
IL229231A0 (en) Preparations and methods for the treatment of cancer
EP2533781A4 (en) METHOD FOR THE TREATMENT OF BLOOD CANCER
SG11201500211PA (en) Composition for preventing or treating osteoarthritis
ZA201305497B (en) Methods and compositions for preventing and treating osteoarthritis
GB201011191D0 (en) Security apparatus
GB0809046D0 (en) Cancer treatment
IL225959A0 (en) Methods and preparations for diagnosis and treatment @ בסרטן
EP2632494A4 (en) METHODS AND COMPOSITIONS FOR EVALUATING AND TREATING CANCER
PT2566506T (pt) Composição de vacina para a prevenção ou tratamento de leishmanioses
GB201019034D0 (en) Treatment for tumors
GB201010588D0 (en) Cancer treatment